(Q44170385)

30 November 2017

title

Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I study (English)

1 reference

adaptive radiation therapy

30 November 2017

main subject

0 references

1 reference

Charles M Rudin

6

0 references

Everett E Vokes

series ordinal

9

object named as

Everett E Vokes

1 reference

30 November 2017

4

Daniel J Haraf

1 reference

30 November 2017

2

Ezra E W Cohen

1 reference

30 November 2017

5

Ann M Mauer

1 reference

30 November 2017

7

Stuart A Krauss

1 reference

30 November 2017

8

Dezheng Huo

1 reference

30 November 2017

Philip C Hoffman

1

1 reference

30 November 2017

Gregory A Masters

series ordinal

3

1 reference

30 November 2017

publication date

1 October 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

38

1 reference

30 November 2017

issue

1

1 reference

30 November 2017

page(s)

65-71

1 reference

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900144-7

7 January 2021

Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900144-7

7 January 2021

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900144-7

7 January 2021

Phase I study of docetaxel with concomitant thoracic radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900144-7

7 January 2021

Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900144-7

7 January 2021

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900144-7

7 January 2021

Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900144-7

7 January 2021

Intensive etoposide and carboplatin chemotherapy for advanced non-small-cell lung cancer. A phase II trial of the Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900144-7

7 January 2021

Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900144-7

7 January 2021

Phase I study of vinorelbine and carboplatin in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900144-7

7 January 2021

A dose-escalating study of carboplatin combined with vinorelbine in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900144-7

7 January 2021

Carboplatin and vinorelbine in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900144-7

7 January 2021

Carboplatin and vinorelbine in untreated locally advanced and metastatic non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900144-7

7 January 2021

Second-line treatment with vinorelbine and carboplatin in patients with advanced non-small cell lung cancer. A multicenter phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900144-7

7 January 2021

Carboplatin and vinorelbine in the treatment of advanced non-small-cell lung cancer: a multicenter phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900144-7

7 January 2021

10.1016/S0169-5002(02)00144-7

Identifiers

DOI

1 reference

30 November 2017

1 reference